Page last updated: 2024-10-31

clorgyline and Chronic Disease

clorgyline has been researched along with Chronic Disease in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karoum, F1
Potkin, S1
Chuang, LW1
Murphy, DL1
Liebowitz, MR1
Wyatt, RJ1

Other Studies

1 other study available for clorgyline and Chronic Disease

ArticleYear
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
    Biological psychiatry, 1984, Volume: 19, Issue:2

    Topics: Carbidopa; Chronic Disease; Clorgyline; Depressive Disorder; Female; Humans; Male; Pargyline; Phenet

1984